Author:
Fonović Urša Pečar,Jevnikar Zala,Kos Janko
Abstract
Abstract
CX3CL1 chemokine (fractalkine) is highly expressed by vascular smooth muscle cells (VSMCs) in atherosclerotic lesions. Its membrane-bound form promotes cell-cell interactions, whereas the soluble form induces chemotaxis of CX3CR1- expressing leukocytes. We show that the cysteine protease cathepsin S, expressed by VSMCs, is able to cleave membrane-anchored CX3CL1, releasing a 55-kDa fragment to the medium, thus regulating the adhesion of VSMCs and the capture of monocytes to the sites of atherogenesis. Moreover, strong co-localization of cathepsin S and CX3CL1 with a recycling endosome marker Rab11a suggests a processing of CX3CL1 in recycling endosomes during its redistribution to the plasma membrane.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference26 articles.
1. Expression of the elastolytic cathepsins in human atheroma and regulation of their production in smooth muscle cells;Sukhova;Clin Invest,1998
2. Gene Profiling in atherosclerosis reveals a key role for small inducible cytokines : validation using a novel monocyte chemoattractant protein monoclonal antibody;Lutgens;Circulation,2005
3. Decreased atherosclerosis in - mice reveals a role for fractalkine in atherogenesis;Lesnik;Clin Invest,2003
4. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain;Clark;Proc Natl Acad Sci USA,2007
5. Tumor necrosis factor - α - converting enzyme ADAM mediates the cleavage and shedding of fractalkine;Garton;Biol Chem,2001
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献